Home › Li-Fraumeni Syndrome › NCT05126810

Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling

Evaluate Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling Based on LFSPRO-ShinyApp Data

Who can join

All ages · All sexes

Inclusion Criteria:

* Individuals age 15 or older OR parent/guardian of a patient younger than 15 years (if age 15-17, the patient will provide assent and parent/guardian will provide consent), pregnant women will also be allowed to participate
* English fluency
* Receive genetic counseling specifically for TP53 genetic testing and who consent to undergo TP53 genetic testing OR individuals whose genetic testing indicates a TP53 germline mutation

Exclusion Criteria:

* Individuals who are non-English speaking
* Individuals having low suspicion for a TP53 germline mutation during pretest counseling and test negative for a TP53 mutation

About the study

This study evaluates patients willingness to participate in a trial comparing standard genetic counseling versus personalized genetic counseling. Collecting information from patients may help researchers learn why patients may or may not take part in the future study that compares standard genetic counseling to personalized genetic counseling.

What is being tested

• Questionnaire Administration (other)

Sponsor: M.D. Anderson Cancer Center · Participants: 500 · Started: Nov 3, 2022

Contact the study team

• Banu Arun · Phone: 713-792-2360

Official record on ClinicalTrials.gov — NCT05126810

Locations in the U.S.

Conditions

• Li-Fraumeni Syndrome

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.